Whitehawk Therapeutics, Inc. (WHWK) Tops Q1 EPS by 218c

Whitehawk Therapeutics, Inc. (NASDAQ: WHWK) reported Q1 EPS of $1.83, $2.18 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $7.14 million versus the consensus estimate of $0 .

For earnings history and earnings-related data on Whitehawk Therapeutics, Inc. (WHWK) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Hyatt Hotels (H) files mixed shelf
• Agnico Eagle subsidiary adds to Canada Nickel stake via private placement